Xeljanz Special Investigation for Long-term Use in UC Patients

Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers

NCT03236493 ·Status: COMPLETED ·Phase: PHASE1

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

NCT06619990 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

NCT03398148 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03915769 ·Status: COMPLETED ·Phase: PHASE3

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06049017 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.

NCT01863771 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis

NCT03398135 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis

NCT03531892 ·Status: COMPLETED ·Phase: PHASE3

A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT00853099 ·Status: COMPLETED ·Phase: PHASE3

Safety and Pharmacokinetic Study of PF-06651600 in Japanese Healthy Volunteers

NCT03232905 ·Status: COMPLETED ·Phase: PHASE1

A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice

NCT04963725 ·Status: COMPLETED

Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

NCT04023396 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis

NCT00694980 ·Status: COMPLETED ·Phase: PHASE1

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT04630028 ·Status: COMPLETED ·Phase: PHASE3

MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients

NCT01959165 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis

NCT03368118 ·Status: COMPLETED ·Phase: PHASE2

A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

NCT04738942 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis

NCT00038922 ·Status: TERMINATED ·Phase: PHASE1

Basiliximab in Moderate to Severe Ulcerative Colitis

NCT00430898 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

NCT00036439 ·Status: COMPLETED ·Phase: PHASE3

Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

NCT03824561 ·Status: COMPLETED

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

NCT01551290 ·Status: COMPLETED ·Phase: PHASE3

Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease

NCT02038920 ·Status: COMPLETED ·Phase: PHASE3

Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases

NCT03606499 ·Status: COMPLETED

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

NCT03093259 ·Status: COMPLETED ·Phase: PHASE2